WallStreetZenWallStreetZen

NASDAQ: FTH
Faeth Therapeutics Inc Stock Ownership - Who owns Faeth Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Faeth Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Brian C. StephensonChief Financial Officer2026-07-01600$24.22
$14.53kBuy
Brian C. StephensonChief Financial Officer2026-07-014,400$23.40
$102.96kBuy
Brian C. StephensonChief Financial Officer2026-06-304,255$24.98
$106.29kBuy
Brian C. StephensonChief Financial Officer2026-06-301,638$23.88
$39.12kBuy
Brian C. StephensonChief Financial Officer2026-06-301,910$22.95
$43.83kBuy
Brian C. StephensonChief Financial Officer2026-06-29831$23.34
$19.40kBuy
Brian C. StephensonChief Financial Officer2026-06-26580$23.61
$13.69kBuy
Brian C. StephensonChief Financial Officer2026-06-26100$26.39
$2.64kBuy
Brian C. StephensonChief Financial Officer2026-06-261,358$25.55
$34.70kBuy
Brian C. StephensonChief Financial Officer2026-06-264,212$24.90
$104.88kBuy

1 of 10

FTH insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FTH insiders and whales buy or sell their stock.

FTH Shareholders

What type of owners hold Faeth Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Hs Investments I LP17.13%4,425,998$146.06MInsider
Khosla Ventures VI LP3.83%988,883$32.63MInsider
Anand Kiran Parikh3.16%817,699$26.98MInsider
Thomas G. Ricks2.65%685,632$22.63MInsider
James Peyer1.10%285,284$9.41MInsider
Cambrian Biopharma Inc0.50%130,142$4.29MInsider
Millennium Management LLC0.49%127,095$4.19MInsider
John Celebi0.41%105,862$3.49MInsider
Robert Hamilton Pierce0.37%94,463$3.12MInsider
Erin Colgan0.26%67,462$2.23MInsider

1 of 3

FTH vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FTH0.05%30.96%Net BuyingNet Buying
PHAR0.00%0.00%
DBVT0.01%11.36%Net SellingNet Selling
RIGL0.07%99.93%Net SellingNet Selling
ACHV0.08%16.80%Net Selling
View Top Biotech Stocks

Faeth Therapeutics Stock Ownership FAQ

Who owns Faeth Therapeutics?

Faeth Therapeutics (NASDAQ: FTH) is owned by 0.05% institutional shareholders, 30.96% Faeth Therapeutics insiders, and 68.99% retail investors. Hs Investments I LP is the largest individual Faeth Therapeutics shareholder, owning 4.43M shares representing 17.13% of the company. Hs Investments I LP's Faeth Therapeutics shares are currently valued at $146.54M.

If you're new to stock investing, here's how to buy Faeth Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.